History of autoimmune disease
People with autoimmune disease
Patients must not have any known autoimmune disease
History of autoimmune disease, with the exception of an autoimmune event associated with prior ipilimumab (anti-CTLA-4) therapy that has been completely resolved for more than 4 weeks prior to C1D1.
History of autoimmune disease
Has an active or inactive autoimmune process
History of autoimmune disease
History of autoimmune disease
Active or history of autoimmune disease or immune deficiency;
Active or history of autoimmune disease or immune deficiency
Participant must not have an active or prior documented autoimmune disease in the last 2 years.
Active autoimmune disease
Active autoimmune disease
History of autoimmune disease
History of autoimmune disease
History or evidence of symptomatic autoimmune pneumonitis, glomerulonephritis, vasculitis, or other systemic autoimmune disease.
History of symptomatic autoimmune disease
Active autoimmune disease requiring treatment for suppression of inflammation with the exception of autoimmune thyroiditis
Active autoimmune disease
Any active or inactive autoimmune disease or syndrome
Active autoimmune disease or a history of severe autoimmune disease or syndrome
History of, active or suspicion of autoimmune disease
History of autoimmune disease
Active or history of autoimmune disease or immune deficiency
History or risk of autoimmune disease
Active or history of autoimmune disease or immune deficiency
Active autoimmune disease or a documented history of autoimmune disease.
Active or known autoimmune disease
History of autoimmune disease
History of autoimmune disease
Patients with any active autoimmune disease
Patients with autoimmune disease
History of major organ autoimmune disease
Active or history of autoimmune disease or immune deficiency;
History of autoimmune disease
Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids, should be excluded
Active or history of autoimmune disease or immune deficiency
Active or prior documented autoimmune or inflammatory disease with some exceptions
History of or current active autoimmune diseases
Patients/subjects with autoimmune disease
History of autoimmune disease
Active or history of autoimmune disease or immune deficiency
Patients who are on treatment for an autoimmune disease, unless specifically approved by the Investigator and the Sponsor.
Active autoimmune disease or a history of severe autoimmune disease or syndrome
Current autoimmune disease or history of autoimmune disease with potential CNS involvement.
History of major organ autoimmune disease.
Has a history of clinically severe autoimmune disease, or history of organ transplant
Patients with history of or active autoimmune disease including thyroiditis, colitis, nephritis, neuropathy or pneumonitis
History of severe autoimmune disease
Participants with chronic autoimmune disease
clinical history, prior diagnosis, or overt evidence of autoimmune disease
Active or history of medically significant autoimmune disease
History of autoimmune disease
FOR ALL PHASES (Ib AND II): History of, or current autoimmune disease
Patients with chronic autoimmune disease
Patients with active known autoimmune disease are ineligible
Patients who are on treatment for rheumatological or autoimmune disease unless approved by the Investigator in consultation with the Sponsor (e.g., as for replacement therapy for autoimmune thyroiditis or diabetes).
Active uncontrolled autoimmune cytopenias
Active or chronic autoimmune diseases
Patients/subjects with autoimmune disease
Has an active autoimmune disease or history of autoimmune disease such as hepatitis, hypophysitis, nephritis, hyperthyroidism or hypothyroidism, interstitial lung disease, colitis
History of major organ autoimmune disease
Those with active autoimmune disease are excluded from the study
Active autoimmune disease.
History of major organ autoimmune disease
History of autoimmune disease(s)
Ongoing or recent significant autoimmune disease
Autoimmune disease
History of active autoimmune disease
Must not have active autoimmune disease (see protocol for exceptions)
History of chronic inflammatory or autoimmune disease
Active autoimmune disease requiring systemic therapy. Patients with a history of autoimmune disease must be counselled regarding the unknown potential of exacerbating or reactivating previous or dormant autoimmunity during the consent process.
Known autoimmune disease
History of prior or current autoimmune disease
Active autoimmune diseases requiring treatment or a history of autoimmune disease that might be stimulated by vaccine treatment; however, patients with vitiligo, diabetes mellitus, and Hashimoto thyroiditis on appropriate replacement therapy may be enrolled
History of autoimmune disease, except for vitiligo, diabetes, and autoimmune thyroiditis
Patients with active autoimmune disease or history of transplantation; patients with indolent or chronic autoimmune disease not requiring steroid treatment are considered eligible
DONOR: History of autoimmune disease
No current or prior autoimmune disease with the exception of vitiligo and autoimmune alopecia (Arm B only)
Active or inactive autoimmune process.
Active autoimmune disease or a documented history of autoimmune disease within 3 years before Screening (or as indicated below), including the following:
Active autoimmune or auto-inflammatory ocular disease within 6 months
Patients with an active autoimmune disease
History of autoimmune disease as detailed above
Patients with active or documented history of autoimmune disease;
Has active autoimmune disease or history of autoimmune diseases at high risk for relapse
Presence at Screening of active immune deficiency or autoimmune disease and/or prior history of any immune deficiency or autoimmune disease that may relapse
Active autoimmune disease or documented history of autoimmune disease.
Any active autoimmune disease
Active autoimmune disease or a documented history of autoimmune disease.
Active autoimmune disease
Must not have been diagnosed with autoimmune disease or be immunosuppressed
Active autoimmune disease prior to transplant
Have history of uncontrolled autoimmune disease.
History of autoimmune disease
History of major organ autoimmune disease
Has active autoimmune disease or history of transplantation
Active or history of autoimmune disease or immune deficiency
History of, or current autoimmune disease
Patients with autoimmune disease requiring systemic corticosteroid treatment (and previously ineligible to receive systemic immunotherapies for melanoma) are allowed on condition that they do not receive more than 20 mg of daily dose methylprednisolone, prednisone, or its equivalent; this does not include autoimmune diseases caused by previous immunotherapy treatments for melanoma that require ongoing treatment with corticosteroids (e.g. autoimmune colitis or autoimmune hepatitis receiving corticosteroids)
Patients with a history of autoimmune disease requiring continuous treatment
Subjects with a history of known autoimmune disease are excluded from this study
Autoimmune disease
Patients with a history of autoimmune disease will also be excluded, specifically those with any active autoimmune disease or a condition that requires systemic corticosteroids; exceptions to this are subjects with vitiligo and type I diabetes mellitus, who will be permitted to enroll
Patients should have no evidence of being immunocompromised as listed below:\r\n* Human immunodeficiency virus positivity\r\n* Active autoimmune diseases requiring treatment or a history of autoimmune disease that might be stimulated by vaccine treatment; patients with endocrine disease that is controlled by replacement therapy including thyroid disease and adrenal disease and vitiligo may be enrolled\r\n* History of splenectomy
Active autoimmune diseases requiring treatment or a recent history of autoimmune disease requiring therapy, including, but not limited to, inflammatory bowel disease, Crohn's disease, ulcerative colitis, or active diverticulitis; however, patients with vitiligo may be enrolled; (patients with history of autoimmune thyroid conditions will be allowed as these patients will be on replacement medications)
Known autoimmune disease or presence of autoimmune phenomena
Subjects with any active autoimmune disease or a history of known autoimmune disease
Active autoimmune disease
Active autoimmune disease or a documented history of autoimmune disease
Subjects with any active or inactive autoimmune process
Subjects with any active or inactive autoimmune process
Has an active autoimmune disease.
Active or chronic autoimmune diseases
History of autoimmune disease.
History of autoimmune disease
Active or prior documented autoimmune or inflammatory disease within 3 years with some exceptions
Active or history of autoimmune disease or immune deficiency
Active autoimmune disease.
Active or inactive autoimmune disease or syndrome.
Subjects who have known active autoimmune disease or a history of autoimmune disease which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids;
History of autoimmune disease
Subject must not have history or evidence of symptomatic autoimmune pneumonitis, glomerulonephritis, vasculitis, or other symptomatic autoimmune disease.
Active or prior documented autoimmune disease within the last 2 years.
History of autoimmune disease
History of autoimmune disease
History of autoimmune disease
Current autoimmune disease or history of autoimmune disease with potential of CNS involvement
History of autoimmune disease
Active autoimmune disease, motor neuropathy considered of autoimmune origin, and other central nervous system (CNS) autoimmune disease.
Patients with active autoimmune disease. (Patients with endocrine autoimmune diseases requiring replacement therapy alone are allowed.)
History of autoimmune disease
Has active autoimmune disease.
Subjects with active autoimmune diseases or history of autoimmune diseases should be excluded.
History of autoimmune disease
Active autoimmune disease
Subjects who have any active or inactive autoimmune disease or syndrome.
Patients with active autoimmune disease
History of systemic autoimmune disease, as patients with ongoing autoimmunity may be at an increased risk of autoimmune toxicity from the study vaccine
History of autoimmune disease
Active or prior autoimmune disease or history of immunodeficiency.
History of autoimmune disease
Active or prior autoimmune disease or history of immunodeficiency
History of autoimmune disease
History of autoimmune disease
Active or prior autoimmune disease except for autoimmune thyroiditis or vitiligo.
Active or history of autoimmune disease or immune deficiency
Clinically active autoimmune disease.
Previous clinical evidence of an autoimmune disease
History of autoimmune disease, with the exception of an autoimmune event associated with prior ipilimumab (anti-cytotoxic T-lymphocyte antigen 4 [CTLA-4]) therapy that has been completely resolved for more than 4 weeks
Active or history of autoimmune disease
Any active or history of a known autoimmune disease
Active autoimmune disease
Has a history of clinically severe autoimmune disease, or history of organ transplant
Patients with uncontrolled autoimmune diseases.
Has an active or inactive autoimmune process.
Active autoimmune disease or a documented history of autoimmune disease.
Active autoimmune disease, history of autoimmune disease
Active autoimmune disease or history of known autoimmune disease
Active autoimmune disease or documented history of autoimmune disease.
Active autoimmune disease or a documented history of autoimmune disease.
Active or uncontrolled autoimmune disease that may require corticosteroid therapy during study
History of autoimmune diseases
Active or inactive autoimmune process.
Active autoimmune disease
Active or prior documented autoimmune or inflammatory disease within 3 years with some exceptions.
History of autoimmune diseases
Patient with an autoimmune condition
Patients with active autoimmune disease or history of transplantation
History of autoimmune disease
Active autoimmune diseases requiring treatment or a history of autoimmune disease.
Active autoimmune diseases requiring treatment or a history of autoimmune disease that might be stimulated by vaccine treatment; however, patients with vitiligo or clinically stable autoimmune endocrine disease who are on appropriate replacement therapy (if such therapy is indicated) are eligible
Active or history of autoimmune disease
Current autoimmune disease or history of autoimmune disease with potential CNS involvement
Previous diagnosis of autoimmune disease (Exceptions: patients with autoimmune thyroiditis or vitiligo may be enrolled)
Active or history of autoimmune disease
Autoimmune disease
Active or history of autoimmune disease
Active autoimmune disease.
History of autoimmune disease
History of autoimmune disease
Active uncontrolled autoimmune disease or active inflammatory disease
History of autoimmune disease
History of autoimmune disease, with the exception of an autoimmune event associated with prior ipilimumab (anti-cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4]) therapy that has completely resolved for a period of more than 4 weeks
Prior history of uveitis or autoimmune inflammatory eye disease
History of serious autoimmune disease;
Autoimmune disease
History of autoimmune disease
History of or active autoimmune disease
Patients with autoimmune disease
Active systemic infection or autoimmune disease
History of uncontrolled autoimmune disease or on active treatment
Known autoimmune disease
RECIPIENT: Diagnosis with autoimmune disease
History of autoimmune disease
Receiving active treatment for cancer or an autoimmune condition
Active or history of autoimmune disease or immune deficiency
History of autoimmune disease
History of autoimmune disease
Autoimmune diseases or immune deficiency disease
Cancer or autoimmune disease under treatment.
Active autoimmune disease or documented history of autoimmune disease.
Has an active autoimmune disease
History of autoimmune hepatitis
Active or history of autoimmune disease
Subjects with any active autoimmune disease or a history of known autoimmune disease
Active autoimmune disease
Active/uncontrolled autoimmune disease
Active/uncontrolled autoimmune disease
History of autoimmune disease
Active autoimmune disease, motor neuropathy considered of autoimmune origin, or other central nervous system autoimmune disease.
